Sigma solid but best days are over claims analyst
MELBOURNE: Pharmacy giant Sigma Healthcare’s “best days for growth are behind it”, says Morningstar analyst… read more
Big pipeline, juicy margins remains GemLife’s IPO Pitch
BRISBANE: ASX aspirant GemLife says it has a bigger pipeline than $815 million listed rival… read more
Proxy advisers support Mayne Pharma deal despite bitter lawsuit
MELBOURNE: A legal dispute between Mayne Pharma and private equity suitor Cosette, which has terminated… read more
